Research Roundup: Dwarf planet candidate, first U.S. adult custom prosthesis, hope for accessible, image-based cancer detection 

Published Nov. 16, 2026, 12:56 a.m., last updated Nov. 16, 2026, 1:54 a.m.

Rubin Observatory identifies dwarf planet candidate that could offer insights to the solar system’s outer reaches

The U.S. National Science Foundation (NSF)–Department of Energy (DOE) Vera C. Rubin Observatory, jointly operated by NSF’s National Optical-Infrared Astronomy Research Laboratory (NOIRLab) and SLAC National Accelerator Laboratory, identified a distant object named 2026 ED138. ED138 offers scientists potential ways to investigate the solar system’s distant peripheries. 

The observatory is a federal initiative funded by the NSF and the DOE Office of Science. The telescope is located on the mountaintop of Cerro Pachón in Chile. 

Scientists have identified 2026 ED138 as a large, bright trans-Neptunian object, which means ED138 is a body that orbits the Sun beyond Neptune. 

ED138’s distance from the sun puts it beyond the orbit of the dwarf planet Pluto. While Pluto was initially identified as a planet, it was reclassified as a dwarf planet in 2006 because it failed to meet all three criteria for a full-sized planet established by the International Astronomical Union.

A dwarf planet is a celestial body that orbits the Sun, has sufficient mass for its own gravity to give it a nearly round shape and has not cleared its orbital neighborhood according to the International Astronomical Union. If its dwarf planet candidacy is confirmed, ED138 would be among the largest of its icy brethren.

Matthew Holman, a Rubin Operations team member and in-kind contributor, discovered the candidate and continues to improve Rubin’s algorithms that search for far, moving objects in the solar system. Researchers found that early analysis indicates that ED138 may be one of the largest and brightest bodies scientists have discovered in the known regions of our planetary system.

“Rubin Observatory’s superpower is the ability to clearly capture movement and change among a vast number of objects and phenomena that humans have never seen before,” Edward Ajhar, NSF Program Director for Rubin Observatory, told the Stanford Report. “That power greatly extends our ability to reveal and understand new things about our solar system, the Milky Way and billions of other galaxies across the universe.”

When Holman discovered ED138 by using a code he co-wrote to look at billions of detections of moving objects, he noticed that its brightness and distance values were unusually large. “My first reaction was one of excited disbelief,” Holman said. “Objects like this are very rare, so I immediately started checking whether I or the code had done something wrong.”

Currently, ED138 is at a current distance of approximately 46 astronomical units (au), where 1 au is the average distance between the Earth and the sun. As reference, dwarf planet Pluto has an average distance of 40 au. 

“Rubin is giving us an unprecedented capacity to explore the sky through a combination of speed, depth, and precision,” Mario Jurić, faculty at the University of Washington and Rubin solar system Lead Scientist, told the Stanford Report. “And the discovery is just the beginning: once we identify a new object, we can search back months, and sometimes even decades, finding it in images where nobody knew to look. This ability to both discover and ‘precover’ objects is transforming how quickly and accurately we can determine their orbits and understand the distant solar system.”

If the team confirms ED138’s dwarf planet status, it would join the five dwarf planets recognized by the IAU: Pluto, Ceres, Eris, Haumea and Makemake. The public can interact with Orbitviewer to explore the structure of ED138 and our cosmic universe three-dimensionally, in realtime.

Medical team reconstructs chest with first adult U.S. implantation of a custom prosthesis after rare cancer surgery

In the School of Medicine, a team of surgical specialists performed a complex chest wall reconstruction in hopes of granting their patient a healthier future. During the 16-hour operation, the team successfully removed the tumor, along with five ribs and portions of the lung and clavicle. They reconstructed the chest using a patient-tailored prosthesis, marking the first adult implantation of the company’s chest wall reconstruction device in the United States.

The tumor was tested and revealed to be Ewing sarcoma, an aggressive, rare cancer that affects bone and soft-tissue.

The procedural team was led by Leah Backhus ’95, M.D., M.P.H., who specializes in adult chest surgery and founded Stanford’s Adult Chest Wall Surgery Program, and Lillian Tsai, M.D., a thoracic surgeon at Stanford’s Thoracic Surgery Clinic. They spent several months collaborating with a multidisciplinary team of physicians across Stanford’s School of Medicine campus, gathering insights and obtaining additional data to plan how to remove the tumor and how to reconstruct the chest wall to restore its appearance and function.

“There really was no good existing prosthesis option on the shelf,” Backhus, the Thelma and Henry Doelger Professor of Cardiovascular Surgery at Stanford Medicine, told Stanford Medicine. “We needed to look outside the box.”

Backhus had explored an innovative, customized chest wall prosthesis made by Osteobionix, a Spanish company dedicated to designing and manufacturing patient-specific 3D-printed implants and surgical guides for complex bone and cartilage reconstruction. The medical team saw potential when the prosthesis offered flexibility with spring-like rib architecture and promising upper body mobility.

The cardiothoracic surgeons joined forces with David Mohler ’79, M.D., Clinical Professor of Orthopedic Surgery, and Paige Fox, M.D., Ph.D., Professor of Plastic and Reconstructive Surgery, to devise a reconstructive plan.

Stanford’s 3D and Quantitative (3DQ) Imaging Lab assisted the reconstruction framework: using the patient’s imaging, the 3DQ lab built a physical model that highlighted the tumor’s position relative to the nearby bones and nerves. The team used it to map incisions, rehearse the operation and anticipate clinical decisions.

The success of the individual procedure was possible by the efforts of teams from thoracic surgery, plastic surgery, orthopedic surgery, anesthesiology, the 3DQ Imaging Lab,and many others behind the scenes. “We hope this case paves the way for future patients,” Tsai told Stanford Medicine. “Through meticulous planning, collaboration, and a creative approach, we overcame significant challenges—and we hope that sharing our experience makes it easier for others to pursue novel solutions for their patients.”

Research team explores whether medical software could maintain accurate cancer detection with lower-resolution images and smaller AI models

Researchers in Stanford’s Department of Biomedical Data Science developed Med-REDUCE, an initiative to explore whether medical AI detection could still produce accurate readings with less image detail and smaller models, according to Stanford Medicine. As powerful models require expensive computing equipment, decreasing the sharpness and scale of input data could allow rural clinics and remote areas to access these technologies. 

The research team, led by former Stanford postdoctoral scholar Vasiliki Bikia, Sonnet Xu ’27, and senior author Dr. Roxana Daneshjou, Assistant Professor of Biomedical Data Science and Dermatology, published a study outlining their findings. 

Sourcing medical images from dermatology, pathology, and radiology, the researchers evaluated three AI “vision models” trained to recognize patterns in melanoma from noncancerous skin spots, classify lung and brain tumors, predict certain cancer-related mutations and identify abnormalities on chest X-rays.

“We kept making the images smaller and less detailed, and were surprised by how well they did. Then we made the models much smaller and got equally good results,” Bikia told Stanford Medicine.

To understand how reducing image resolution affected model performance, the team progressively reduced image dimensions from 512 × 512 pixels to 64 × 64 pixels, a 64-fold pixel reduction. All three AI models retained most of their accuracy. 

The team hopes to continue exploring smaller model potential. “Even the most powerful AI is of little use if clinics can’t afford it,” Daneshjou, who is also faculty affiliate for Stanford Human-centered Artificial Intelligence (HAI) and the AI in Medicine and Imaging (AIMI) Center, told Stanford Medicine.

Med-REDUCE is still a work-in-progress. This study involved using existing imaging datasets with pretrained AI models. Future testing is needed to determine whether their approach can function reliably in real-world healthcare settings and across patient populations.

The team’s findings could eventually support the development of portable imaging devices that use smaller AI models requiring less computing power. Such technologies could help narrow technological disparities between well-resourced medical centers and smaller or geographically isolated healthcare facilities.



Login or create an account